

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to exogenous dsRNA (GO:0071360) | 6.52612867 |
| 2 | cytoplasmic mRNA processing body assembly (GO:0033962) | 6.06504084 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.17835611 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.17835611 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.17835611 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.17835611 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.17835611 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.17835611 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.14879986 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99446474 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.99446474 |
| 12 | response to peptidoglycan (GO:0032494) | 4.98189058 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.96011835 |
| 14 | DNA replication checkpoint (GO:0000076) | 4.76037061 |
| 15 | respiratory burst (GO:0045730) | 4.69626580 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.67261435 |
| 17 | defense response to protozoan (GO:0042832) | 4.65003738 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.61907143 |
| 19 | positive regulation of mast cell activation (GO:0033005) | 4.34659330 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.33016110 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.32308865 |
| 22 | glycosphingolipid catabolic process (GO:0046479) | 4.27385663 |
| 23 | response to protozoan (GO:0001562) | 4.26662405 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.23377476 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.21131707 |
| 26 | leukocyte aggregation (GO:0070486) | 4.16842755 |
| 27 | detection of other organism (GO:0098543) | 4.10215649 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06574576 |
| 29 | cellular response to interferon-beta (GO:0035458) | 3.95971797 |
| 30 | detection of bacterium (GO:0016045) | 3.88132041 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87554861 |
| 32 | regulation of mast cell activation (GO:0033003) | 3.87073972 |
| 33 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.86811382 |
| 34 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.84314825 |
| 35 | negative regulation of phagocytosis (GO:0050765) | 3.83945399 |
| 36 | germinal center formation (GO:0002467) | 3.81254915 |
| 37 | glycolipid catabolic process (GO:0019377) | 3.79130909 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.78272622 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76358989 |
| 40 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.75165728 |
| 41 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.74367250 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.72550038 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70692708 |
| 44 | microglial cell activation (GO:0001774) | 3.70240787 |
| 45 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.68896675 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.64482825 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.64482825 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60006195 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.59706809 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56003028 |
| 51 | positive regulation of interleukin-12 production (GO:0032735) | 3.52889192 |
| 52 | cellular response to dsRNA (GO:0071359) | 3.52343056 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.51608250 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48710855 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47571823 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46009574 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 3.45233159 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.42736796 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.42133259 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.40827713 |
| 61 | neutrophil mediated immunity (GO:0002446) | 3.35642364 |
| 62 | ceramide catabolic process (GO:0046514) | 3.35202377 |
| 63 | negative regulation of B cell activation (GO:0050869) | 3.34897780 |
| 64 | pinocytosis (GO:0006907) | 3.34362266 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.33278698 |
| 66 | B cell mediated immunity (GO:0019724) | 3.30636400 |
| 67 | mast cell activation (GO:0045576) | 3.28882508 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.28842277 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 3.28122397 |
| 70 | positive regulation of leukocyte degranulation (GO:0043302) | 3.27529896 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 3.26564154 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23744139 |
| 73 | response to host immune response (GO:0052572) | 3.23744139 |
| 74 | regulation of hypersensitivity (GO:0002883) | 3.22746464 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.21714571 |
| 76 | neutrophil activation (GO:0042119) | 3.21639634 |
| 77 | necroptotic process (GO:0070266) | 3.17301717 |
| 78 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16226400 |
| 79 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.15775164 |
| 80 | T cell migration (GO:0072678) | 3.14839258 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14045893 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13687357 |
| 83 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.12833450 |
| 84 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11698062 |
| 85 | cellular response to type I interferon (GO:0071357) | 3.10357193 |
| 86 | type I interferon signaling pathway (GO:0060337) | 3.10357193 |
| 87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09189199 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 3.08515583 |
| 89 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07790316 |
| 90 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.07098611 |
| 91 | negative regulation of growth of symbiont in host (GO:0044130) | 3.06195756 |
| 92 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.06195756 |
| 93 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.06195756 |
| 94 | regulation of growth of symbiont in host (GO:0044126) | 3.06195756 |
| 95 | response to host (GO:0075136) | 3.04629800 |
| 96 | response to host defenses (GO:0052200) | 3.04629800 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04629800 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03174462 |
| 99 | response to type I interferon (GO:0034340) | 3.03037041 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01958628 |
| 101 | myeloid cell activation involved in immune response (GO:0002275) | 3.01259567 |
| 102 | response to exogenous dsRNA (GO:0043330) | 2.99934495 |
| 103 | iron ion import (GO:0097286) | 2.99922511 |
| 104 | cellular extravasation (GO:0045123) | 2.99495303 |
| 105 | leukocyte degranulation (GO:0043299) | 2.99357392 |
| 106 | programmed necrotic cell death (GO:0097300) | 2.98718091 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98704265 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97960462 |
| 109 | neutrophil chemotaxis (GO:0030593) | 2.96041177 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94949462 |
| 111 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.92985186 |
| 112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92586714 |
| 113 | regulation of regulated secretory pathway (GO:1903305) | 2.92087710 |
| 114 | myeloid leukocyte activation (GO:0002274) | 2.91936517 |
| 115 | myoblast migration (GO:0051451) | 2.90980396 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90812964 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.90170533 |
| 118 | positive regulation of type 2 immune response (GO:0002830) | 2.90027704 |
| 119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.89640594 |
| 120 | regulation of respiratory burst (GO:0060263) | 2.89619021 |
| 121 | neutrophil migration (GO:1990266) | 2.88468123 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88416374 |
| 123 | granulocyte activation (GO:0036230) | 2.87312255 |
| 124 | sphingolipid catabolic process (GO:0030149) | 2.86959030 |
| 125 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 2.86518937 |
| 126 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.85725008 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.85119506 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84911038 |
| 129 | myeloid leukocyte mediated immunity (GO:0002444) | 2.83702203 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.82107944 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.81752391 |
| 132 | positive regulation of mast cell degranulation (GO:0043306) | 2.81368037 |
| 133 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81368037 |
| 134 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79465707 |
| 135 | regulation of interleukin-12 production (GO:0032655) | 2.78464196 |
| 136 | negative regulation of innate immune response (GO:0045824) | 2.77291643 |
| 137 | response to interferon-beta (GO:0035456) | 2.76666345 |
| 138 | cellular response to interferon-gamma (GO:0071346) | 2.76521149 |
| 139 | myeloid dendritic cell differentiation (GO:0043011) | 2.76006641 |
| 140 | regulation of histone phosphorylation (GO:0033127) | 2.75980879 |
| 141 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75801480 |
| 142 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.74080746 |
| 143 | macrophage activation (GO:0042116) | 2.73737973 |
| 144 | regulation of interleukin-17 production (GO:0032660) | 2.72624262 |
| 145 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70579919 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.68909791 |
| 147 | positive regulation of interleukin-10 production (GO:0032733) | 2.68117215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.31838624 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.00186577 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.42328329 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.44540159 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.16977860 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.16566590 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.74175546 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73071651 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.56030102 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.46152744 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30813469 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07973781 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96746089 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49791623 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.46532261 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42921350 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39595858 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32315236 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.27412813 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26775797 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19816015 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.17868543 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10951361 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.02803675 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00722966 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98052598 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94409027 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89608136 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84891930 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84135128 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.82907697 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.80581313 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80512882 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79224925 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71641398 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.71513601 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69996786 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68888911 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.67734875 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65056351 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62623499 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60866945 |
| 43 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57883006 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55568891 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54894997 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50993110 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50905227 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46370344 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45245931 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42171896 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41457308 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39079105 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37628799 |
| 54 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33741272 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28023014 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27465453 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26853943 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26514971 |
| 59 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.26020682 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25535009 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25496535 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22667725 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22553806 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22395488 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21153989 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20774319 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18650578 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17736084 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17254395 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13776065 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13306946 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13035744 |
| 73 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13024762 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11946539 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10794310 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08767128 |
| 77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07660041 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07250436 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.04711768 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04661699 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03621268 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03233722 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02887505 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01385108 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00482357 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97570563 |
| 87 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97393266 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97187267 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96587337 |
| 90 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96527908 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95900368 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95874267 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92358985 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91849484 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91716515 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90900973 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89457667 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89397322 |
| 99 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88304746 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87577169 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86887271 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85833331 |
| 103 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85510123 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83335284 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83101219 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83008516 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80427539 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80197699 |
| 109 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78271914 |
| 110 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78179220 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77767761 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.77145423 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77110867 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76785680 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76769187 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76135206 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75651245 |
| 118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75250622 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72827334 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.71015079 |
| 121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69617821 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67416290 |
| 123 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67145284 |
| 124 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66116832 |
| 125 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65613622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.35824549 |
| 2 | MP0003724_increased_susceptibility_to | 3.97921723 |
| 3 | MP0000685_abnormal_immune_system | 2.90762059 |
| 4 | MP0003436_decreased_susceptibility_to | 2.90661219 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.87469486 |
| 6 | MP0003303_peritoneal_inflammation | 2.87386639 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.86139946 |
| 8 | MP0001853_heart_inflammation | 2.83642929 |
| 9 | MP0004147_increased_porphyrin_level | 2.73959287 |
| 10 | MP0002419_abnormal_innate_immunity | 2.72949459 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.71935893 |
| 12 | MP0001800_abnormal_humoral_immune | 2.68044530 |
| 13 | MP0005025_abnormal_response_to | 2.67609845 |
| 14 | MP0001819_abnormal_immune_cell | 2.48257094 |
| 15 | MP0002723_abnormal_immune_serum | 2.45297049 |
| 16 | MP0005671_abnormal_response_to | 2.44444297 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.39389766 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.39079270 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.38565847 |
| 20 | MP0009785_altered_susceptibility_to | 2.36084138 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.31342692 |
| 22 | MP0009278_abnormal_bone_marrow | 2.28321363 |
| 23 | MP0002398_abnormal_bone_marrow | 2.23469500 |
| 24 | MP0001790_abnormal_immune_system | 2.22244497 |
| 25 | MP0005387_immune_system_phenotype | 2.22244497 |
| 26 | MP0009840_abnormal_foam_cell | 2.16904081 |
| 27 | MP0006082_CNS_inflammation | 2.16542745 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.15266924 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 2.09866862 |
| 30 | MP0002006_tumorigenesis | 2.06186649 |
| 31 | MP0000716_abnormal_immune_system | 1.99610392 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.87291160 |
| 33 | MP0000490_abnormal_crypts_of | 1.69590090 |
| 34 | MP0008057_abnormal_DNA_replication | 1.68595506 |
| 35 | MP0002429_abnormal_blood_cell | 1.68174844 |
| 36 | MP0005408_hypopigmentation | 1.65542692 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.65258521 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.64306996 |
| 39 | MP0005451_abnormal_body_composition | 1.63830190 |
| 40 | MP0002405_respiratory_system_inflammati | 1.61744648 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.61171215 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.60945682 |
| 43 | MP0006054_spinal_hemorrhage | 1.58976770 |
| 44 | MP0003077_abnormal_cell_cycle | 1.58305944 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.56041425 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.55911966 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.55656354 |
| 48 | MP0002722_abnormal_immune_system | 1.53564369 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.50461304 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.47920540 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.45142731 |
| 52 | MP0004510_myositis | 1.39047534 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.38992531 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.38863143 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.38383068 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.35919224 |
| 57 | MP0008469_abnormal_protein_level | 1.35087729 |
| 58 | MP0005166_decreased_susceptibility_to | 1.30888984 |
| 59 | MP0003690_abnormal_glial_cell | 1.30092045 |
| 60 | MP0005310_abnormal_salivary_gland | 1.29371107 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.29329194 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.26234598 |
| 63 | MP0009764_decreased_sensitivity_to | 1.21779659 |
| 64 | MP0001873_stomach_inflammation | 1.20608461 |
| 65 | MP0006292_abnormal_olfactory_placode | 1.18940166 |
| 66 | MP0004947_skin_inflammation | 1.16814393 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.15450831 |
| 68 | MP0008004_abnormal_stomach_pH | 1.12995701 |
| 69 | MP0004883_abnormal_blood_vessel | 1.12960264 |
| 70 | MP0008260_abnormal_autophagy | 1.11291341 |
| 71 | MP0001958_emphysema | 1.10811153 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.09944981 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.05302092 |
| 74 | MP0003111_abnormal_nucleus_morphology | 1.04572607 |
| 75 | MP0002254_reproductive_system_inflammat | 1.04145342 |
| 76 | MP0003866_abnormal_defecation | 1.02451872 |
| 77 | MP0005164_abnormal_response_to | 1.02252318 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.99659731 |
| 79 | MP0010307_abnormal_tumor_latency | 0.98912875 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.98192638 |
| 81 | MP0002009_preneoplasia | 0.97858188 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 0.95239168 |
| 83 | MP0002090_abnormal_vision | 0.93764349 |
| 84 | MP0005390_skeleton_phenotype | 0.92555406 |
| 85 | MP0000858_altered_metastatic_potential | 0.92527373 |
| 86 | MP0009763_increased_sensitivity_to | 0.91252077 |
| 87 | MP0000681_abnormal_thyroid_gland | 0.90643140 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.89985807 |
| 89 | MP0000343_altered_response_to | 0.89448091 |
| 90 | MP0002928_abnormal_bile_duct | 0.86879540 |
| 91 | MP0001851_eye_inflammation | 0.85573983 |
| 92 | MP0001915_intracranial_hemorrhage | 0.84424473 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.82472359 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.81990680 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.80024171 |
| 96 | MP0000920_abnormal_myelination | 0.79479084 |
| 97 | MP0003075_altered_response_to | 0.78113678 |
| 98 | MP0003787_abnormal_imprinting | 0.77659290 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.77286298 |
| 100 | MP0003868_abnormal_feces_composition | 0.76240979 |
| 101 | MP0000604_amyloidosis | 0.75820332 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.75628394 |
| 103 | MP0003795_abnormal_bone_structure | 0.75353102 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.74876519 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.74790868 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.74790868 |
| 107 | MP0002933_joint_inflammation | 0.74404857 |
| 108 | MP0003718_maternal_effect | 0.74355419 |
| 109 | MP0009672_abnormal_birth_weight | 0.73206844 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.72638467 |
| 111 | MP0003329_amyloid_beta_deposits | 0.72414735 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.71059435 |
| 113 | MP0003448_altered_tumor_morphology | 0.69857717 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.67739621 |
| 115 | MP0000371_diluted_coat_color | 0.67001879 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.65971842 |
| 117 | MP0001663_abnormal_digestive_system | 0.65587296 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.64437238 |
| 119 | MP0000249_abnormal_blood_vessel | 0.64194863 |
| 120 | MP0008874_decreased_physiological_sensi | 0.63313472 |
| 121 | MP0002132_abnormal_respiratory_system | 0.63252553 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.61653284 |
| 123 | MP0001529_abnormal_vocalization | 0.61150680 |
| 124 | MP0000598_abnormal_liver_morphology | 0.59731484 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.58776973 |
| 126 | MP0001542_abnormal_bone_strength | 0.58364801 |
| 127 | MP0005647_abnormal_sex_gland | 0.57991989 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.57889486 |
| 129 | MP0001119_abnormal_female_reproductive | 0.57544502 |
| 130 | MP0005165_increased_susceptibility_to | 0.56474086 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.56254110 |
| 132 | MP0003828_pulmonary_edema | 0.55535360 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.51623191 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.49785642 |
| 135 | MP0000609_abnormal_liver_physiology | 0.48389899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spinal cord lesions (HP:0100561) | 5.66575432 |
| 2 | Syringomyelia (HP:0003396) | 5.66575432 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.59505191 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.52272886 |
| 5 | Absent frontal sinuses (HP:0002688) | 5.52017086 |
| 6 | Metaphyseal dysplasia (HP:0100255) | 4.64702305 |
| 7 | Stomatitis (HP:0010280) | 4.63169496 |
| 8 | Spondylolisthesis (HP:0003302) | 4.60861787 |
| 9 | Orchitis (HP:0100796) | 4.55029127 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.48626379 |
| 11 | Optic neuritis (HP:0100653) | 4.48626379 |
| 12 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 4.44796585 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.39210129 |
| 14 | Chromsome breakage (HP:0040012) | 4.18175574 |
| 15 | Obstructive lung disease (HP:0006536) | 4.17970192 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.17970192 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 4.06587907 |
| 18 | Cerebral palsy (HP:0100021) | 4.00746313 |
| 19 | Testicular atrophy (HP:0000029) | 3.98600995 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.85912739 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.82162409 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.76433592 |
| 23 | Amyloidosis (HP:0011034) | 3.71833422 |
| 24 | Short middle phalanx of the 5th finger (HP:0004220) | 3.65962360 |
| 25 | Abnormality of lateral ventricle (HP:0030047) | 3.64921116 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.59074417 |
| 27 | Abnormality of the frontal sinuses (HP:0002687) | 3.52160050 |
| 28 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.47264439 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45475706 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45475706 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45475706 |
| 32 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.43670644 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.33391834 |
| 34 | Loss of speech (HP:0002371) | 3.26423252 |
| 35 | Parakeratosis (HP:0001036) | 3.22735398 |
| 36 | Myositis (HP:0100614) | 3.19320893 |
| 37 | Recurrent skin infections (HP:0001581) | 3.14371850 |
| 38 | Agnosia (HP:0010524) | 3.14098935 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 3.09045465 |
| 40 | Meningitis (HP:0001287) | 3.04978858 |
| 41 | Urticaria (HP:0001025) | 3.04793501 |
| 42 | Keratoconjunctivitis (HP:0001096) | 3.02453121 |
| 43 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.02136396 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 3.02100078 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.98954093 |
| 46 | Disinhibition (HP:0000734) | 2.97717096 |
| 47 | Abnormality of the pleura (HP:0002103) | 2.97621991 |
| 48 | Duplicated collecting system (HP:0000081) | 2.96959968 |
| 49 | Encephalitis (HP:0002383) | 2.91969142 |
| 50 | Short 5th finger (HP:0009237) | 2.88307530 |
| 51 | Recurrent viral infections (HP:0004429) | 2.87581674 |
| 52 | Papilledema (HP:0001085) | 2.87148428 |
| 53 | Chronic otitis media (HP:0000389) | 2.85528561 |
| 54 | Thrombocytosis (HP:0001894) | 2.85096306 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81460968 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81460968 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81460968 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.81104521 |
| 59 | Acrocyanosis (HP:0001063) | 2.80293782 |
| 60 | Diminished motivation (HP:0000745) | 2.79560431 |
| 61 | Mutism (HP:0002300) | 2.78341728 |
| 62 | Petechiae (HP:0000967) | 2.74544242 |
| 63 | Apathy (HP:0000741) | 2.74385508 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68581596 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.67698838 |
| 66 | Abnormality of the parietal bone (HP:0002696) | 2.67395281 |
| 67 | T lymphocytopenia (HP:0005403) | 2.64869228 |
| 68 | Abnormality of the renal collecting system (HP:0004742) | 2.63901296 |
| 69 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.62916406 |
| 70 | Hemoptysis (HP:0002105) | 2.61813788 |
| 71 | Renal cortical cysts (HP:0000803) | 2.60436026 |
| 72 | Purpura (HP:0000979) | 2.59933353 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.59046103 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59046103 |
| 75 | Vasculitis (HP:0002633) | 2.58772562 |
| 76 | Neonatal respiratory distress (HP:0002643) | 2.57259255 |
| 77 | Arthropathy (HP:0003040) | 2.55862484 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55372532 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.55255022 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.50004463 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.49415015 |
| 82 | Abnormality of complement system (HP:0005339) | 2.48913806 |
| 83 | Leukocytosis (HP:0001974) | 2.47336745 |
| 84 | Episodic fever (HP:0001954) | 2.46745571 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.41142239 |
| 86 | Chest pain (HP:0100749) | 2.39776874 |
| 87 | Arterial thrombosis (HP:0004420) | 2.37872343 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37674447 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.36350074 |
| 90 | Increased IgE level (HP:0003212) | 2.35951353 |
| 91 | Reticulocytopenia (HP:0001896) | 2.35412691 |
| 92 | Epistaxis (HP:0000421) | 2.32197249 |
| 93 | Pulmonary embolism (HP:0002204) | 2.32148818 |
| 94 | Gangrene (HP:0100758) | 2.31426255 |
| 95 | Flared metaphyses (HP:0003015) | 2.30866515 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.30563490 |
| 97 | Recurrent fungal infections (HP:0002841) | 2.30218290 |
| 98 | Cellulitis (HP:0100658) | 2.28661696 |
| 99 | Lower limb hyperreflexia (HP:0002395) | 2.28453937 |
| 100 | Anorexia (HP:0002039) | 2.27592957 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.27518885 |
| 102 | Polyneuropathy (HP:0001271) | 2.26784872 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.26392549 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.21298534 |
| 105 | Hematochezia (HP:0002573) | 2.20284845 |
| 106 | Exertional dyspnea (HP:0002875) | 2.18211092 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.18147993 |
| 108 | Gingival bleeding (HP:0000225) | 2.16699331 |
| 109 | Hypoplastic iliac wings (HP:0002866) | 2.16092349 |
| 110 | Abnormality of DNA repair (HP:0003254) | 2.12469823 |
| 111 | Abnormality of T cells (HP:0002843) | 2.11411554 |
| 112 | Axonal loss (HP:0003447) | 2.11276292 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 2.10719600 |
| 114 | Mucosal telangiectasiae (HP:0100579) | 2.09299194 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 2.09116172 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.07644903 |
| 117 | Emphysema (HP:0002097) | 2.07214186 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 2.07097328 |
| 119 | Osteomyelitis (HP:0002754) | 2.06384645 |
| 120 | Poor head control (HP:0002421) | 2.06322742 |
| 121 | Clubbing of toes (HP:0100760) | 2.05555503 |
| 122 | Nephritis (HP:0000123) | 2.05313126 |
| 123 | Vertigo (HP:0002321) | 2.05306640 |
| 124 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.04886971 |
| 125 | Increased IgM level (HP:0003496) | 2.04660596 |
| 126 | Skin rash (HP:0000988) | 2.04046995 |
| 127 | Xerostomia (HP:0000217) | 2.04034326 |
| 128 | Neurofibrillary tangles (HP:0002185) | 2.03808704 |
| 129 | Colitis (HP:0002583) | 2.03403595 |
| 130 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.03102300 |
| 131 | IgM deficiency (HP:0002850) | 2.01966204 |
| 132 | Glomerulonephritis (HP:0000099) | 2.01412747 |
| 133 | Ascites (HP:0001541) | 2.00914521 |
| 134 | Prostate neoplasm (HP:0100787) | 1.99745681 |
| 135 | Gastrointestinal stroma tumor (HP:0100723) | 1.97440537 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97206654 |
| 137 | Abnormality of the prostate (HP:0008775) | 1.97019002 |
| 138 | Panhypogammaglobulinemia (HP:0003139) | 1.96871535 |
| 139 | Recurrent pneumonia (HP:0006532) | 1.96339889 |
| 140 | Azoospermia (HP:0000027) | 1.93712865 |
| 141 | Thickened calvaria (HP:0002684) | 1.91847167 |
| 142 | Granulocytopenia (HP:0001913) | 1.91819332 |
| 143 | Myocardial infarction (HP:0001658) | 1.91328720 |
| 144 | Restrictive lung disease (HP:0002091) | 1.91295636 |
| 145 | Glomerulopathy (HP:0100820) | 1.91001001 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.87565529 |
| 147 | Abnormality of the 2nd finger (HP:0004100) | 1.85232523 |
| 148 | Arthralgia (HP:0002829) | 1.84180522 |
| 149 | Abnormal platelet volume (HP:0011876) | 1.83669576 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82888355 |
| 151 | Pulmonary infiltrates (HP:0002113) | 1.82039817 |
| 152 | Pustule (HP:0200039) | 1.81745744 |
| 153 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.78880458 |
| 154 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78859295 |
| 155 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78859295 |
| 156 | Nasal polyposis (HP:0100582) | 1.77381634 |
| 157 | Pulmonary fibrosis (HP:0002206) | 1.77013511 |
| 158 | Supernumerary ribs (HP:0005815) | 1.76517156 |
| 159 | Gingivitis (HP:0000230) | 1.76240289 |
| 160 | Increased serum ferritin (HP:0003281) | 1.75458358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.98499796 |
| 2 | MAP4K1 | 3.80988989 |
| 3 | BRSK2 | 3.58343247 |
| 4 | KIT | 3.46865709 |
| 5 | FLT3 | 3.43110780 |
| 6 | CSF1R | 3.39975244 |
| 7 | TRPM7 | 3.02784508 |
| 8 | IRAK4 | 2.91940623 |
| 9 | SCYL2 | 2.54627044 |
| 10 | MAP3K13 | 2.35527434 |
| 11 | MAP3K14 | 2.28001912 |
| 12 | FGR | 2.27412985 |
| 13 | BLK | 2.26822463 |
| 14 | TBK1 | 2.23550409 |
| 15 | TYK2 | 2.17027474 |
| 16 | BMPR2 | 2.15849719 |
| 17 | STK24 | 2.05113314 |
| 18 | MAP3K6 | 2.04987143 |
| 19 | CSK | 1.90691967 |
| 20 | BRSK1 | 1.82527124 |
| 21 | MARK3 | 1.82306685 |
| 22 | MAP3K11 | 1.80525204 |
| 23 | JAK3 | 1.80202416 |
| 24 | MAP3K3 | 1.78757484 |
| 25 | GRK7 | 1.74043648 |
| 26 | ERN1 | 1.73670887 |
| 27 | RIPK4 | 1.65093106 |
| 28 | IRAK3 | 1.54483366 |
| 29 | TGFBR2 | 1.51374826 |
| 30 | TNK2 | 1.50612003 |
| 31 | IKBKB | 1.47779758 |
| 32 | MAP3K1 | 1.39672817 |
| 33 | NME2 | 1.38983376 |
| 34 | PKN1 | 1.36620025 |
| 35 | FES | 1.36099110 |
| 36 | STK38L | 1.32847578 |
| 37 | IKBKE | 1.28542134 |
| 38 | TEC | 1.27188118 |
| 39 | MAP3K8 | 1.26928635 |
| 40 | MOS | 1.25362289 |
| 41 | ARAF | 1.18379078 |
| 42 | STK10 | 1.14879309 |
| 43 | MAP3K12 | 1.11178904 |
| 44 | SIK3 | 1.10403626 |
| 45 | ITK | 1.06457865 |
| 46 | TAOK1 | 1.06150202 |
| 47 | GRK6 | 1.05669648 |
| 48 | CLK1 | 1.05092209 |
| 49 | CDK9 | 1.03716439 |
| 50 | SYK | 1.01919010 |
| 51 | TESK2 | 1.01080557 |
| 52 | EPHB1 | 0.98278377 |
| 53 | PIM2 | 0.97127542 |
| 54 | RPS6KA6 | 0.93507654 |
| 55 | PDK1 | 0.93184286 |
| 56 | PIM1 | 0.93166353 |
| 57 | LYN | 0.92273701 |
| 58 | SGK2 | 0.91268791 |
| 59 | RPS6KA4 | 0.83047297 |
| 60 | CHEK2 | 0.80284036 |
| 61 | TAOK2 | 0.78839816 |
| 62 | PIK3CG | 0.78086950 |
| 63 | ATR | 0.77172941 |
| 64 | MAPK12 | 0.77103940 |
| 65 | PLK3 | 0.74416304 |
| 66 | HCK | 0.74182085 |
| 67 | CDC42BPA | 0.73322788 |
| 68 | MAP3K5 | 0.70980985 |
| 69 | MUSK | 0.70922223 |
| 70 | STK3 | 0.69790144 |
| 71 | CHUK | 0.69781128 |
| 72 | PRKD2 | 0.69098372 |
| 73 | LCK | 0.67985569 |
| 74 | MAPK7 | 0.66225724 |
| 75 | TTK | 0.65316291 |
| 76 | MELK | 0.65238958 |
| 77 | DDR2 | 0.64533690 |
| 78 | BTK | 0.64042766 |
| 79 | EEF2K | 0.63158913 |
| 80 | CAMKK2 | 0.63113485 |
| 81 | MATK | 0.62393075 |
| 82 | STK11 | 0.61881948 |
| 83 | MARK2 | 0.59918912 |
| 84 | IRAK2 | 0.59820736 |
| 85 | RPS6KC1 | 0.59122977 |
| 86 | RPS6KL1 | 0.59122977 |
| 87 | PLK4 | 0.59122571 |
| 88 | ZAP70 | 0.57624944 |
| 89 | ACVR1B | 0.56914204 |
| 90 | ABL1 | 0.56813332 |
| 91 | MAP2K6 | 0.56129217 |
| 92 | SIK2 | 0.55404058 |
| 93 | JAK1 | 0.55003039 |
| 94 | HIPK2 | 0.54752470 |
| 95 | SGK3 | 0.54619902 |
| 96 | FYN | 0.53940714 |
| 97 | CDK19 | 0.53193291 |
| 98 | KSR2 | 0.53161846 |
| 99 | MAP2K2 | 0.51215494 |
| 100 | IRAK1 | 0.51019189 |
| 101 | ADRBK2 | 0.50353465 |
| 102 | MAP4K2 | 0.49992859 |
| 103 | RIPK1 | 0.49815067 |
| 104 | JAK2 | 0.49317132 |
| 105 | MAPK13 | 0.48132637 |
| 106 | DAPK2 | 0.47558779 |
| 107 | PDPK1 | 0.47088288 |
| 108 | LRRK2 | 0.43634617 |
| 109 | NLK | 0.42807175 |
| 110 | PLK1 | 0.42726653 |
| 111 | STK4 | 0.42672636 |
| 112 | DYRK1B | 0.41474971 |
| 113 | PRKCD | 0.41469051 |
| 114 | CDK6 | 0.41324312 |
| 115 | CAMK1D | 0.39004811 |
| 116 | MAPKAPK2 | 0.38763137 |
| 117 | RPS6KA2 | 0.38653112 |
| 118 | CDC7 | 0.38466885 |
| 119 | DMPK | 0.38045168 |
| 120 | ZAK | 0.37219304 |
| 121 | MAP2K3 | 0.35017431 |
| 122 | SGK223 | 0.34623200 |
| 123 | SGK494 | 0.34623200 |
| 124 | YES1 | 0.34370502 |
| 125 | PRKG2 | 0.34041174 |
| 126 | MAPK4 | 0.33589106 |
| 127 | NUAK1 | 0.31795810 |
| 128 | ATM | 0.31618836 |
| 129 | RAF1 | 0.29200549 |
| 130 | PAK4 | 0.29087850 |
| 131 | VRK1 | 0.28713055 |
| 132 | PRPF4B | 0.27796387 |
| 133 | TXK | 0.27713681 |
| 134 | ABL2 | 0.27364982 |
| 135 | RPS6KB2 | 0.27019721 |
| 136 | INSR | 0.26418751 |
| 137 | RPS6KA1 | 0.25805598 |
| 138 | ERBB4 | 0.25534517 |
| 139 | AURKB | 0.25109229 |
| 140 | PRKCQ | 0.24667438 |
| 141 | PTK2B | 0.24190717 |
| 142 | MAPK3 | 0.23978955 |
| 143 | EGFR | 0.21357915 |
| 144 | PAK1 | 0.20433992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.28821316 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.60662092 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59573187 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52558345 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46292097 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36217649 |
| 7 | RNA degradation_Homo sapiens_hsa03018 | 2.36053798 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.33340779 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25417222 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.17684013 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.09840190 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08180347 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08065062 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.07296154 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06434211 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98548543 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.97938927 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.93373147 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91159725 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86962500 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.86038886 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.84734531 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.79468902 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76474424 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72029840 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.63893219 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.62084046 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60300485 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.59789142 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.52766830 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51686034 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49829338 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49681389 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49161579 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44726231 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.44112809 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42941139 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.35253822 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.34106107 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.30441868 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28282073 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27738952 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26239541 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.17703556 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.16994204 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12890066 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12302606 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.12156074 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10302517 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08312849 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06226745 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05779429 |
| 53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98676929 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98428144 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97254120 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93072929 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91803152 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91448145 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90586245 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90170370 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88082390 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87026419 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85675697 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85369516 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.84632855 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84194430 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.84042549 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81898955 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81058192 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80447127 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80414735 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79222136 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75436091 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72635580 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.72497711 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70838729 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.68481083 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66549743 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65991890 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65165453 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64931079 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64510319 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63800931 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60800497 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58782320 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58521171 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.56148828 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56043693 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52960440 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52771027 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52656006 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52119908 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51238658 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50978599 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50063018 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49646344 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.48925074 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.48919081 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48491169 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48375515 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47431652 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47307771 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.46683590 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44903351 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44370026 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41955931 |
| 107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41245532 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.40740712 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40647486 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.40064870 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38664183 |
| 112 | Allograft rejection_Homo sapiens_hsa05330 | 0.38575192 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37420201 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34869504 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31343563 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29577103 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29532477 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29110210 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28884634 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28839045 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27968950 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27721106 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27494133 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.27039132 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26047064 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.24841245 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.21375801 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20904792 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20479898 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20416451 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18736498 |
| 132 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17602728 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17425936 |
| 134 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15919839 |

